Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Caio Rocha-Lima"'
Autor:
Iben Spanggaard, Marc Matrana, Caio Rocha-Lima, Amit Mahipal, Maria Vieito, Alice Hervieu, Myung-Ju Ahn, Lipika Goyal, Jordi Rodon Ahnert, Luisa Veronese, Natalia Oliveira, Xin Li, Michael Schaffer, Santosh Kesari
Publikováno v:
Monday, April 24.
Autor:
Jaime R. Merchan, Caio Rocha-Lima, Pasquale Benedetto, Jonathan C. Trent, Krisztina Kovacs, Aurea Flores, Deukwoo Kwon, Alberto J. Montero
Purpose: To evaluate the safety, MTD, pharmacokinetics/pharmacodynamics, and early clinical activity of ixabepilone given either weekly or every 3 weeks in combination with daily sunitinib in patients with advanced solid tumors.Experimental Design: E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ca5ec88809267603808877f8531d143
https://doi.org/10.1158/1078-0432.c.6523437.v1
https://doi.org/10.1158/1078-0432.c.6523437.v1
Autor:
Richard Kim, William P. Harris, David Portnoy, Manik Amin, E. Gabriela Chiorean, Caio Rocha-Lima, Jitendra Gandhi, Tao Song
Publikováno v:
British Journal of Cancer
Background: This multicentre, open-label study evaluated the efficacy and safety of SPI-1620, an analogue of endothelin-1, administered in combination with docetaxel as second-line treatment for patients with advanced biliary tract cancer (ABTC). Met
Publikováno v:
Journal of Health Psychology. 21:1331-1338
This study examined the role of ethnicity (Black vs White) in the extent to which patients’ appraisal of the impact of cancer on themselves and their family members relates to their physical health. Colorectal cancer patients provided self-reports
Autor:
Gilberto Lopes, Gail Walker, Carlos Mayo, Jaime R. Merchan, Orlando Silva, Jessica MacIntyre, Caio Rocha-Lima, Soley Bayraktar, Mark R. Green, Heloisa P. Soares, Joe U. Levi, Marcelo Blaya
Publikováno v:
Cancer Chemotherapy and Pharmacology. 73:839-845
Docetaxel and capecitabine combination is synergistic in preclinical models. We investigated the efficacy and toxicity of this combination as second-line chemotherapy in patients with metastatic pancreatic adenocarcinoma (mPC), pretreated with gemcit
Autor:
Jose M. Yrizarry, Jaime R. Merchan, Isabelle C. Beulaygue, Govindarajan Narayanan, Joseph U. Levi, Ana Echenique, Tatiana Froud, Hester J. Scheffer, Peter J. Hosein, Elizabeth C. Hevert, Caio Rocha-Lima, Alan S. Livingstone, Riccardo Lencioni, Shree Venkat
Publikováno v:
Journal of Vascular and Interventional Radiology, 28(3), 342-348. Elsevier Inc.
Narayanan, G, Hosein, P J, Beulaygue, I C, Froud, T, Scheffer, H J, Venkat, S R, Echenique, A M, Hevert, E C, Livingstone, A S, Rocha-Lima, C M, Merchan, J R, Levi, J U, Yrizarry, J M & Lencioni, R 2017, ' Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma ', Journal of Vascular and Interventional Radiology, vol. 28, no. 3, pp. 342-348 . https://doi.org/10.1016/j.jvir.2016.10.023
Narayanan, G, Hosein, P J, Beulaygue, I C, Froud, T, Scheffer, H J, Venkat, S R, Echenique, A M, Hevert, E C, Livingstone, A S, Rocha-Lima, C M, Merchan, J R, Levi, J U, Yrizarry, J M & Lencioni, R 2017, ' Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma ', Journal of Vascular and Interventional Radiology, vol. 28, no. 3, pp. 342-348 . https://doi.org/10.1016/j.jvir.2016.10.023
Purpose To describe safety and effectiveness of percutaneous irreversible electroporation (IRE) for treatment of unresectable, locally advanced pancreatic adenocarcinoma (LAPC). Materials and Methods This retrospective study included 50 patients (23
Autor:
Alberto J. Montero, Caio Rocha-Lima, Deukwoo Kwon, Pasquale Benedetto, Aurea M. Flores, Jonathan C. Trent, Jaime R. Merchan, Krisztina Kovacs
Purpose: To evaluate the safety, MTD, pharmacokinetics/pharmacodynamics, and early clinical activity of ixabepilone given either weekly or every 3 weeks in combination with daily sunitinib in patients with advanced solid tumors. Experimental Design:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3b2e4b9513778eb136f3cbe64ae95c8
https://europepmc.org/articles/PMC4930738/
https://europepmc.org/articles/PMC4930738/
Autor:
Edward B. Garon, Jesse McGreivy, Elwyn Loh, Y. J. Hei, D. Chan, Howard Safran, L.E. Garbo, Charles S. Fuchs, D. Richards, Hedy L. Kindler, Francesco Galimi, Sarah Bray, J.J. Stephenson, D.M. Kocs, E. G. Feigal, Caio Rocha-Lima
Publikováno v:
Annals of Oncology. 23:2834-2842
Background We evaluated the efficacy and safety of ganitumab (a mAb antagonist of insulin-like growth factor 1 receptor) or conatumumab (a mAb agonist of human death receptor 5) combined with gemcitabine in a randomized phase 2 trial in patients with
Autor:
Joe U. Levi, Caio Rocha-Lima, Aurea M. Flores, Danny Sleeman, Jessica MacIntyre, Annaporna Ferrell, Afonso Ribeiro, Kristen K. Ciombor, Jaime R. Merchan, Gilberto Lopes
Publikováno v:
American Journal of Clinical Oncology. 35:446-450
OBJECTIVE: Little progress has been made in the treatment of pancreatic cancer (PC). This study evaluated the clinical activity of gemcitabine, oxaliplatin, and cetuximab (GOC) in patients with locally advanced or metastatic PC. METHODS: The study pr
Publikováno v:
Psycho-Oncology. 22:362-367
Objective Few studies have examined prospectively and longitudinally depressive symptoms of family caregivers who provide care to colorectal cancer patients, and fewer have addressed ethnic minorities in this regard. This study investigated the relat